Đang chuẩn bị liên kết để tải về tài liệu:
Durvalumab for extensive stage of small-cell lung cancer with lambert-eaton myasthenic syndrome

Durvalumab is an immune checkpoint inhibitor (ICI) of anti-programmed cell death protein 1 ligand antibody. ICI-combined chemotherapy has recently become a standard regimen for extensive-stage of small-cell lung cancer (ES-SCLC). |